Reviva Pharmaceuticals Holdings (RVPH) Other financing activities (2018 - 2026)

Reviva Pharmaceuticals Holdings has reported Other financing activities for 6 years, with the latest figure at $8.0 in Q1 2026.

• Quarterly Other financing activities fell 100.0% year-over-year to $8.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 2691.41% YoY) and the FY2025 annual result came in at $7.0 million, up 4681822.82% from the prior year.
• Other financing activities eased to $8.0 in Q1 2026 per RVPH's latest filing, from $6.7 million in the prior quarter.
• Over five years, Other financing activities peaked at $6.7 million in Q4 2025 and troughed at $8.0 in Q1 2026.
• A 5-year average of $792995.4 and a median of $9448.0 in 2022 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2025 and 2026: Other financing activities jumped 5907742.11% in 2025, then slumped 100.0% in 2026.
• Over 5 years, Other financing activities stood at $18563.0 in 2022, then jumped by 4830.09% to $915173.0 in 2023, then plunged by 99.99% to $114.0 in 2024, then surged by 5907742.11% to $6.7 million in 2025, then tumbled by 100.0% to $8.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $8.0, $6.7 million, and $241125.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.